EHC - European Haemophilia Consortium / LinkedIn
Dec 16, 2025, 00:32
New on EHCucate: Read about the “History of Replacement Factor Therapies” and More
European Haemophilia Consortium shared a post on LinkedIn:
“From fresh-frozen plasma in the 1950s to today’s extended and ultra-long half-life products—the evolution of replacement factor treatments for bleeding disorders showcases over 70 years of remarkable innovation and ingenuity, culminating in personalised therapy.
Want to dive deeper? Explore these new topics on the EHCucate webpage:
- History of Replacement Factor Therapies (RFT)
- Principles of Factor Replacement
- Practical Foundations of RFT

Learn more”
Follow the latest in Hemostasis Today.
-
Oct 8, 2026, 13:35Manuel Monreal: Why IVC Filter Retrieval Matters for VTE Outcomes
-
Oct 8, 2026, 12:53Hellen Ishikawa-Ankerhold: PhD and Postdoctoral Positions in Advanced Microscopy and Immunothrombosis at LMU Munich
-
Oct 8, 2026, 12:45Pedro Perez: World Thrombosis Day 2026 – Raising Awareness of Women’s VTE Risk
-
Oct 8, 2026, 12:20Berrin Gunaydin: Functional Biomarkers of Iron Deficiency in Pregnancy
-
Oct 8, 2026, 11:45Wolfgang Miesbach: Milvexian After Acute Coronary Syndrome – What LIBREXIA ACS Found
-
Oct 8, 2026, 11:36John Erbey: Kidney Disfunction as a Cause of Anemia
-
Oct 8, 2026, 11:31Navneet Mishra: Sitosterolemia as an Under-Recognised Cause of Cytopenias
-
Oct 8, 2026, 11:06Houman Khosravani: Stroke and Thrombosis – Bridging Neurology and Hemostasis
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis